Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Heparin Market, by Product Type (Unfractionated Heparin (UH), Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMW)), by Dosage Form (Injection, and Solutions), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

Published Date : May 2019

Heparin Market – Insights Heparin is used to prevent or treat certain blood vessel, heart, and lung conditions. It is also used in blood transfusion, blood samplings during prophylaxis treatment, and fo

Coherent Market Insights
Beta Glucan Based Products Market, by Source (Cereals, Yeast, Mushroom, and Others), by Grade (Pharma, Medical, Food, Cosmetics, Enhanced Oil Recovery (EOR), and Animal Feed), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019- 2027

Published Date : May 2019

Global Beta Glucan Based Products Market – Global Industry Insights Beta glucan is a valuable dietary ?ber present in cereal crops, especially in barley, oat, and some mushrooms. According to the EC Nut

Coherent Market Insights
Hepatic Encephalopathy Market, by Drug Class (Antibiotic, Laxatives, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019- 2027

Published Date : May 2019

Global Hepatic Encephalopathy Market – Global Industry Insights Hepatic encephalopathy (HE) is a neuropsychiatric complication commonly associated with the liver disease: cirrhosis. The inability of the

Coherent Market Insights
Cordyceps Sinensis and Militaris Extract Market, by Formulation (Tablet/Capsule, Liquid, Powder), by Application (Medicine, Dietary Supplements, Food Additives), by Strain Type (Cordyceps Sinensis and Cordyceps Militaris) – Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published Date : Apr 2019

Cordyceps Sinensis and Militaris Extract Market Insights Cordyceps Sinensis and C. militaris is a combination of parasitic fungus species and dead caterpillars that offer several potential health applications

Coherent Market Insights
Primary Biliary Cholangitis Treatment Market, by Treatment Type by Treatment Type (Ursodeoxycholic acid (UDCA), and Obeticholic acid (Ocaliva)), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published Date : Mar 2019

Primary Biliary Cholangitis Treatment Market Insights Primary biliary cirrhosis, also known as primary biliary cholangitis is a chronic liver disease, which causes liver inflammation, fibrosis, and obstructio

Coherent Market Insights
Silver Sulfadiazine Market – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Jun 2019

Silver sulfadiazine is specifically used for second degree or third-degree burns on the skin, which acts ant-bacterial drug. The World Health Organization considers silver sulfadiazine as an Essential Medicines and is used as an antibiotic for skin burns. Silver sulfa

Coherent Market Insights
Regulatory Affairs Outsourcing Market, by Service Type (Regulatory Submission, Regulatory Writing and Publication, Clinical Trail Application and Product Registration, and Regulatory Consulting and Legal Presentation) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2019-2026

To Be Published : Jun 2019

The regulatory affair outsourcing companies are responsible for keeping track about the regulatory requirements specific to regions, in order to ensure that the company have successfully launches and commercializes pharmaceutical products, medical devices, biologics,

Coherent Market Insights
Peptide-based Cardiovascular Therapeutics Market, by Drug Type (Bivalirudin and Eptifibatide), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook and Opportunity Analysis, 2019-2027

To Be Published : Jun 2019

Cardiovascular diseases remain a leading cause of mortality and morbidity worldwide. The development of peptide as therapeutic agent has been avoided by pharmaceutical industry due to its low stability, size, degradation rate, and poor stability. However, recently, re

Coherent Market Insights
Enrofloxacin Market - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Jun 2019

The global enrofloxacin market size is expected to witness potential gains in the future, and register a significant CAGR over the forecast period (2019 - 2027). Market Overview

Coherent Market Insights
Aluminum Chloride Hexahydrate Market - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Jun 2019

Aluminum chloride hexahydrate is white to pale in color crystalline powder, which is stable at room temperature. However, it may decompose when it is exposed to moist air or water. According to Oxford University Chemical Safety data, aluminum chloride hexahydrate has

Coherent Market Insights
Histone Deacetylase Inhibitors Market, by Drug (Zolinza (Vorinostat), Istodax (Romidepsin), Beleodaq (Belinostat), Farydak (Panabinostat) and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Jun 2019

Histone deacetylases (HDACs), also called as lysine deacetylases, are enzymes that remove acetyl group from the lysine (amino acid) present on histones. This ensures wrapping up of histones on the DNA more tightly and suppresses the gene effect. Histone acetyltransfer

Coherent Market Insights
Carglumic Acid Market by Dosage Form- By Tablet (Oral Disintegration Tablet and Dispersible Tablets), By Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026

To Be Published : Jun 2019

Carglumic acid is an orphan drug used for the treatment of hyperammonemia. Hyperammonemia is a rare genetic disorder characterized by elevated level of ammonia in the blood. Increased entry of ammonia is a primary cause of neurological disorders such as congenital def

Coherent Market Insights
Novel Drugs and Devices to Lower Intraocular Pressure Market, by Treatment Type (Drug (Rhopressa, Roclatan, Xelpros, Vyzulta and Others) and Device (Implant, Therapeutic Ultrasound and Others), by Distribution Channel (Hospitals & Clinics, Retail Channel and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

To Be Published : Jun 2019

Intraocular pressure is the pressure present inside the eye. The aqueous humour of the ciliary body in the eye is responsible for the intraocular pressure. The production and removal rate of aqueous humour by the ciliary body determines the pressure in the eye. The pr

Coherent Market Insights
Tourette Syndrome Treatment Market, by Drug Class (Antiadrenergic Agents, Antipsychotic Agents, Atypical Antipsychotics, Carbonic Anhydrase Inhibitor Anticonvulsants, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026

To Be Published : Jun 2019

Tourette syndrome is a rare and severe neurological disorder which causes tics. Tic is a repetitive involuntary movements, sudden, no rhythmic motor movements. It occurs due to the mutations of the SLITRK1 gene, which plays an important role in development of nerve ce

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.